<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02426268</url>
  </required_header>
  <id_info>
    <org_study_id>FORE-SIGHT 13-000448</org_study_id>
    <nct_id>NCT02426268</nct_id>
  </id_info>
  <brief_title>FORE-SIGHT Tissue Oximeter During Cardiac Surgery</brief_title>
  <acronym>FORE-SIGHT</acronym>
  <official_title>CAS Medical Systems FORE-SIGHT Elite Tissue Oximeter During Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Los Angeles</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>CAS Medical Systems, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, Los Angeles</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to measure cerebral and lower extremity oximetry on patients&#xD;
      during cardiac surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this research study is to collect data from a tissue oximeter device that&#xD;
      measures brain oxygen saturation simultaneous with data from the same device that monitors&#xD;
      skeletal muscle during cardiac surgery. This monitoring will allow for continuous,&#xD;
      non-invasive, and earlier assessment of perfusion abnormalities/hypoperfusion.&#xD;
&#xD;
      Two sensors from the FORE-SIGHT Elite monitor will be placed on the forehead above the&#xD;
      eyebrows and two additional sensors will be placed on the leg muscles. Data from the&#xD;
      FORE-SIGHT Elite monitor will be recorded in addition to clinical and demographic data, which&#xD;
      is standard of care during the procedure, for research purposes to look at factors associated&#xD;
      with desaturations.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2014</start_date>
  <completion_date type="Actual">November 21, 2019</completion_date>
  <primary_completion_date type="Actual">June 6, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cerebral Oxygen Saturation</measure>
    <time_frame>Duration of the surgery (~5-7 hours)</time_frame>
    <description>Two sensors from FORE-SIGHT Elite monitor will be placed on the forehead above the eyebrows to continuously monitor cerebral oxygen saturation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Non-Cerebral Oxygen Saturation</measure>
    <time_frame>Duration of the surgery (~5-7 hours)</time_frame>
    <description>Two sensors from FORE-SIGHT Elite monitor will be placed on the leg muscles to continuously monitor non-cerebral/skeletal muscle oxygen saturation.</description>
  </secondary_outcome>
  <enrollment type="Actual">55</enrollment>
  <condition>Cardiac Surgical Patients</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Cardiothoracic surgical population at UCLA&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects where cerebral oximetry is monitored during their surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Birthmarks, tattoos, or other skin abnormalities that FORE-SIGHT Sensors cannot avoid&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emily Methangkool, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Los Angeles</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ronald Reagan UCLA Medical Center, Department of Anesthesiology</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>April 21, 2015</study_first_submitted>
  <study_first_submitted_qc>April 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 24, 2015</study_first_posted>
  <last_update_submitted>November 2, 2020</last_update_submitted>
  <last_update_submitted_qc>November 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Los Angeles</investigator_affiliation>
    <investigator_full_name>Emily Methangkool, MD, MPH</investigator_full_name>
    <investigator_title>Assistant Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>cardiac surgery</keyword>
  <keyword>cerebral oximetry</keyword>
  <keyword>lower extremity oximetry</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

